Cidara Therapeutics, Inc. (CDTX)

220.15 +0.05 (+0.02%) USD  |  NASDAQ  |  Dec 16, 15:53
More

Cidara Therapeutics Total Expenses (Annual)

Total Expenses (Annual) Chart

View Total Expenses (Annual) for CDTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Annual) Range, Past 5 Years

View Total Expenses (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Annual) Benchmarks

View Total Expenses (Annual) Benchmarks
Start Trial
Merck & Co., Inc. Upgrade
Mersana Therapeutics, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Johnson & Johnson Upgrade
Pfizer Inc. Upgrade